banner add

How a Company Makes Millions Off a Hospital Program Meant to Help the Poor

A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills.

from NYT > Health https://ift.tt/Euzleab
via IFTTT

No comments

Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an immunotherapy trial offe...

Theme images by PLAINVIEW. Powered by Blogger.